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Book Reviews
Antitumour Drug-Radiation Interactions
B.T. Hill & A.S. Bellamy. Florida: CRC Press. 1990, 284 pp.
This book comprehensively addresses the very important area
of interactions between chemotherapeutic drugs and radia-
tion. It deals with each of the commonly used cytotoxic
drugs and the potential for interaction with radiation based
on stem cell kinetic and basic radiobiological principles.
There is a vast amount of valuable information in this book
and it represents an excellent reference textbook for workers
involved in the area.
Commonly used cytotoxic drugs and their interactions with
radiation are dealt with in separate chapters, with the in-
formation clearly and concisely presented. Therefore the data
and references are easy to access, but not surprisingly, as
many of the mechanisms involved in drug radiation inter-
actions may be similar between drugs, there is a degree of
repetition throughout the book. There is an impressive list of
contributors to this textbook, and there is naturally some
variability between chapters, but the editors have successfully
managed to maintain format and style. I found three chap-
ters particularly interesting. The first dealt with interactions
involving adriamycin, actinomycin and radiation. The data
are clearly presented dealing with effects on both normal and
neoplastic cells, including drug resistant cells. There are many
helpful graphs and the data is excellently summarised. The
chapter dealing with 5-fluoro-uracil and radiation again con-
tained clear, well presented figures, effectively summarising
both pre-clinical and early clinical studies, pointing out the
important areas for future research. Also, the chapter dealing
with mitomycin C and radiation covered important areas
such as the effect of hypoxia on sensitivity to both agents,
and reviewed the limited clinical studies, pointing out the
possibility of therapeutic gain with such a combination.
Obviously from the clinical stand-point the situation is
disappointing, with the only significant positive interaction
described relating to the combination of 5FU and radiation.
The book identifies the difficulty of developing experimental
models for the investigation of sensitive tumours where com-
bination chemotherapy is normally used, where the benefit of
combined modality treatment is likely to be maximal and
where optimum scheduling of treatments may be critical.
On the other hand, there were areas where the book was
disappointing. It is frequently inferred that current experi-
mental model systems are inadequate and unlikely to have
direct applicability to the clinical situation, with no clear
ideas on how these models could be improved. The chapter
dealing with resistance and future perspectives could have, in
addition addressed the problem from a different stand-point,
perhaps outlining how developments in molecular biology
may help us to understand some of these complex inter-
actions and hopefully offer some insight into the develop-
ment of more rational and effective combined modality
treatments in the future.
In conclusion, this book represents an excellent summary
of our current knowledge on drug radiation interactions. As
this topic is not extensively covered, I am sure it will be a
valuable source of reference for many workers in the area,
including radiobiologists, radiation oncologists and medical
oncologists.
J. Carmichael
Genetic Basis for Carcinogenesis. Tumor Suppressor Genes
and Oncogenes
Edited by A.G. Knudson, E.J., Standbridge, T. Sugimura,
M. Terada & S. Watanabe, London: Taylor & Frances Ltd.,
1990, 381 pp. £48.00.
This is a book of a meeting, but not the sort where there's
the chummy discussion after each talk, with everyone being
called by their first names. Rather, it's a collection of papers,
carefully and somewhat formally written, mindful, perhaps,
of the presence on the day of Princess Kikuko Takamatsu.
What I particularly like about this book is the chapter
length - an average of five pages. I find this is just right for
me to read in entirety a piece of work outside my own area
of interest; any longer and I start skimming. There are two
slightly longer chapters - the text of two lectures by the
conference organisers, Alfred Knudson and Eric Stanbridge,
but these are also eminently readable. Stanbridge reviews the
evidence for the existence of tumour suppressor genes and
Knudson provides a very useful catalogue of the cancers
involving inherited predisposition and reviews what is known
about the molecular genetics of each. Following the two
lectures are six separate sections dealing with various aspects
of oncogenes and tumour suppressor genes by many of the
names which come to mind when these topics are mentioned.
These chapters are all very well written: no evidence of hasty
scrabbling together of a few lecture notes. However, this is
probably reflected in the date of publication, more than a
year after the Symposium. This of course means that not all
the work is up to date, some areas obviously suffering more
than others - the chapter on the genetic analysis of colon
carcinoma, written before the isolation of the DCC, MCC
and APC genes, being the prime example. However, the
scope of the book is wide, so that being absolutely up to date
is not its prime function.
There's a spate of books on tumour suppressor genes at
the moment. Multi-author books such as this one have the
advantage of each chapter being written by an expert and the
possible disadvantage of not being completely comprehensive
- and this is certainly true of this book, for example, the
oncogene section does not have a chapter on ras.
Overall, one to advise the librarian to buy rather than to
add to a personal collection.
P. Rabbitts